GFM
PACB icon

GF Fund Management’s Pacific Biosciences PACB Stock Holding History

GF Fund Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.85K Buy
6,705
+773
+13% +$1.38K ﹤0.01% 569
2025
Q4 		$11.1K Sell
5,932
-530
-8% -$1.02K ﹤0.01% 565
2025
Q3 		$8.27K Sell
6,462
-329
-5% -$446 ﹤0.01% 570
2025
Q2 		$8.42K Hold
6,791
– – ﹤0.01% 585
2025
Q1 		$8.01K Buy
6,791
+1,041
+18% +$1.6K ﹤0.01% 587
2024
Q4 		$10.5K Buy
+5,750
New +$11.2K ﹤0.01% 540

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GF Fund Management's PACB Position: Q1 2026 in Review

GF Fund Management increased its Pacific Biosciences (PACB) stake by 13% in Q1 2026, buying an estimated $1.38K and bringing the position to 6,705 shares worth $8.85K. The position accounts for ﹤0.01% of the portfolio, ranked #569.

GF Fund Management first reported a position in PACB in Q4 2024 and has held it in 6 quarters since. The position peaked at $11.1K in Q4 2025. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • GF Fund Management held 6,705 shares of Pacific Biosciences worth $8.85K as of Q1 2026.
  • GF Fund Management bought 773 Pacific Biosciences shares in Q1 2026, an estimated $1.38K.
  • Pacific Biosciences made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #569 holding.
  • GF Fund Management first reported a position in Pacific Biosciences in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Pacific Biosciences position peaked at $11.1K in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.